Surdacki Andrzej, Stochmal Ewa, Szurkowska Magdalena, Bode-Böger Stefanie M, Martens-Lobenhoffer Jens, Stochmal Anna, Klecha Artur, Kawecka-Jaszcz Kalina, Dubiel Jacek S, Huszno Bohdan, Szybiński Zbigniew
2nd Department of Cardiology, Jagiellonian University, 31-501 Cracow, Poland.
Metabolism. 2007 Jan;56(1):77-86. doi: 10.1016/j.metabol.2006.08.023.
Partially inconsistent data exist on mutual relations between nontraditional atherosclerotic risk factors, including the magnitude of insulin resistance (IR), as well as on their relevance for atherogenesis in the metabolic syndrome. Subjects exhibiting combined impaired fasting glucose and impaired glucose tolerance (IFG/IGT) are exposed to an exceptionally high risk for atherogenesis and development of type 2 diabetes mellitus. Because of islet Beta-cell dysfunction, the usefulness of commonly used indices of IR is limited in IFG/IGT. Our aim was to assess the relationship between extent of angiographic coronary artery disease (CAD) and nontraditional atherosclerotic risk factors (including IR by a clamp-based golden standard method) in IFG/IGT. Fifty-three subjects (32 men, 21 women; mean age, 55 +/- 11 years) with stable angina, preserved left ventricular systolic function, and IFG/IGT were divided into 3 groups: group A (no coronary stenoses >50%, n = 22), group B (1-vessel CAD, n = 15), and group C (2/3-vessel CAD, n = 16). Insulin sensitivity was quantified by a hyperinsulinemic euglycemic clamp technique and expressed as M. M value, plasma homocysteine (Hcy) level, and asymmetric dimethyl-L-arginine (ADMA)/L-arginine ratio were independent determinants of CAD extent as shown by forward stepwise discriminant function analysis. Compared with group A (M = 32.7 +/- 9.3 micromol/kg fat-free mass [FFM] per minute; Hcy, 8.1 +/- 1.4 micromol/L), lower M and higher Hcy levels were found in group B (M = 16.9 +/- 8.2 micromol/kg FFM per minute, P < .001; Hcy, 11.2 +/- 2.9 micromol/L, P = .003) and C (M = 16.4 +/- 7.8 micromol/kg FFM per minute, P < .001; Hcy, 12.8 +/- 3.9 micromol/L, P < .001). The ADMA/L-arginine ratio was increased in group C (0.0078 +/- 0.0011) compared with group A (0.0063 +/- 0.0013, P = .03) and B (0.0058 +/- 0.0012, P = .01). Multivariate correlates (P < .05) of plasma Hcy concentrations were M (beta = -.34 +/- .12, P = .008), creatinine clearance (beta = -.23 +/- .10, P = .03) and fasting insulin (beta = .25 +/- .12, P = .04). This indicates an additive contribution of IR, plasma Hcy, and elevated ADMA/L-arginine ratio to the extent of angiographic CAD in combined IFG/IGT.
关于非传统动脉粥样硬化危险因素之间的相互关系,包括胰岛素抵抗(IR)的程度,以及它们在代谢综合征中与动脉粥样硬化发生的相关性,存在部分不一致的数据。表现为空腹血糖受损和糖耐量受损(IFG/IGT)的受试者面临动脉粥样硬化和2型糖尿病发生的极高风险。由于胰岛β细胞功能障碍,常用的IR指标在IFG/IGT中的作用有限。我们的目的是评估IFG/IGT患者中血管造影显示的冠状动脉疾病(CAD)程度与非传统动脉粥样硬化危险因素(包括通过基于钳夹的金标准方法测定的IR)之间的关系。53例患有稳定型心绞痛、左心室收缩功能保留且有IFG/IGT的受试者(32例男性,21例女性;平均年龄55±11岁)被分为3组:A组(无冠状动脉狭窄>50%,n = 22),B组(单支血管CAD,n = 15),C组(双支/三支血管CAD,n = 16)。通过高胰岛素正常血糖钳夹技术对胰岛素敏感性进行量化,并表示为M。正向逐步判别函数分析显示,M值、血浆同型半胱氨酸(Hcy)水平和不对称二甲基-L-精氨酸(ADMA)/L-精氨酸比值是CAD程度的独立决定因素。与A组(M = 32.7±9.3微摩尔/千克去脂体重[FFM]每分钟;Hcy,8.1±1.4微摩尔/升)相比,B组(M = 16.9±8.2微摩尔/千克FFM每分钟,P <.001;Hcy,11.2±2.9微摩尔/升,P =.003)和C组(M = 16.4±7.8微摩尔/千克FFM每分钟,P <.00(1);Hcy,12.8±3.9微摩尔/升,P <.001)的M值较低,Hcy水平较高。与A组(0.0063±0.0013,P =.03)和B组(0.0058±0.0012,P =.01)相比(,)C组的ADMA/L-精氨酸比值升高(0.0078±0.0011)。血浆Hcy浓度的多变量相关因素(P <.05)为M(β = -0.34±0.12,P =.008)、肌酐清除率(β = -0.23±0.10,P =.03)和空腹胰岛素(β = 0.25±0.12,P =.04)。这表明在合并IFG/IGT的情况下,IR、血浆Hcy和升高的ADMA/L-精氨酸比值对血管造影显示的CAD程度有累加作用。